Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series

In Japan, drug therapy for schizophrenia is characterized by high-dose antipsychotic polypharmacy, which is an uncommon approach internationally. In this study, we reduced the number of antipsychotic agents in 5 patients using the Safety Correction of High-dose Antipsychotic Polypharmacy (SCAP) meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamei, Hiroyuki, Yamada, Hanae, Hatano, Masakazu, Hanya, Manako, Yamada, Shigeki, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006980/
https://www.ncbi.nlm.nih.gov/pubmed/31958917
http://dx.doi.org/10.9758/cpn.2020.18.1.159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006980/
https://www.ncbi.nlm.nih.gov/pubmed/31958917
http://dx.doi.org/10.9758/cpn.2020.18.1.159

Ejemplares similares